Document Detail


Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
MedLine Citation:
PMID:  9339235     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Desmopressin (DDAVP), a synthetic analogue of vasopressin, has been shown to improve the bleeding time in patients with cirrhosis. The duration of this effect and the hemodynamic changes associated with DDAVP have not been studied so far. To evaluate these issues, 14 cirrhotics with portal hypertension were studied in basal conditions and after DDAVP (0.3 uk/kg). In 8 patients, hemostatic tests were done at basal conditions and 1, 3, 6 and 24 hs after drug administration. In the remaining 6 patients, mean arterial pressure, cardiac output, portal and femoral blood flows were evaluated. Hemodynamic parameters were measured by Doppler ultrasound. DDVP caused a marked decrease in bleeding time at 1, 3, 6 and 24 hs (14 +/- 9 vs 8 +/- 3, 7 +/- 4, 6 +/- 4 and 8 +/- 4 min, respectively); the decrease was maximal and statistically significant at 6 hs (55 +/- 15%, p < 0.02) after DDAVP infusion. Bleeding time reduction was observed in every patient studied. In the hemodynamic study, DDAVP caused a mild but significant decrease in mean arterial pressure (12 +/- 8%, p < 0.05); no significant changes were observed in the rest of hemodynamic parameters studied. These findings show that DDAVP can be used to shorten the bleeding time for a period of at least 24 hs in patients with cirrhosis, without deleterious hemodynamic effects. This beneficial effect may be of potential relevance in the medical management of patients with chronic liver diseases.
Authors:
P López; J C Otaso; D Alvarez; S Rojter; A Podestá; L Albornoz; R Terg; G Romero; R Mastai
Related Documents :
8104495 - Effect of portal hypertension on bacterial translocation induced by major liver resecti...
9536955 - The relationship between intrahepatic portal systemic shunts and microsphere induced po...
19699975 - Minimally invasive measurement of esophageal variceal pressure and wall tension (with v...
22215705 - Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal betamethas...
22493075 - Influence of high glycemic index and glycemic load diets on blood pressure during adole...
17275755 - Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of bru...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Acta gastroenterologica Latinoamericana     Volume:  27     ISSN:  0300-9033     ISO Abbreviation:  Acta Gastroenterol. Latinoam.     Publication Date:  1997  
Date Detail:
Created Date:  1997-12-02     Completed Date:  1997-12-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0261505     Medline TA:  Acta Gastroenterol Latinoam     Country:  ARGENTINA    
Other Details:
Languages:  eng     Pagination:  59-62     Citation Subset:  IM    
Affiliation:
Sección de Hígado, Hospital Italiano, Buenos Aires, Argentina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bleeding Time
Deamino Arginine Vasopressin / pharmacology*,  therapeutic use
Female
Hemodynamics / drug effects*
Hemostasis / drug effects*
Humans
Hypertension, Portal / drug therapy*
Liver Cirrhosis / drug therapy*
Male
Middle Aged
Renal Agents / pharmacology*,  therapeutic use
Time Factors
Chemical
Reg. No./Substance:
0/Renal Agents; 16679-58-6/Deamino Arginine Vasopressin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thioctic acid protection against ethanol-induced gastric mucosal lesions involves sulfhydryl and pro...
Next Document:  Esophageal motility disorders in Mexican patients with Duchenne's muscular dystrophy.